Conditions: Anemia; Esophageal Cancer; Gastric Cancer
Intervention: Drug: Iron isomaltoside 1000
Sponsors: Nottingham University Hospitals NHS Trust; Pharmacosmos A/S
Recruiting - verified October 2016
http://ift.tt/2eOJouM
http://ift.tt/2dTmH3O
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 18 July 2017 Source: Journal of Voice Author(s): E. Lucchini, A. Ricci Maccarini, E. Bissoni, M. Borrag...
-
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182, alsfakia@gmail.com http://ift.tt/...
-
http://ift.tt/2rzpBWF Alexandros Sfakianakis Anapafseos 5 . Agios Nikolaos Crete.Greece.72100 2841026182 6948891480 alsfakia@gma...
-
A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µ...
-
Abstract Objectives To investigate the association of residential mobility with flourishing among school-age children. Methods Data from...
-
Abstract The present document describes the SIUMB (Italian Society of Ultrasound in Medicine and Biology) guidelines for the use of ultras...
-
Related Articles Clinically relevant concentrations of anticancer drugs: A guide for non-clinical studies. Clin Cancer Res. 2017 Mar ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου